Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation

References

• Sureda A, Bader P, Cesaro S, for the European Society for Blood and Marrow Transplantation, et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015;50:1037–1056.
   PubMed Web of Science ®Google Scholar
• Kelly D, Theodoratou E, Farrington S, et al. The contributions of adjusted ambient ultraviolet B radiation at place of residence and other determinants to serum 25-hydroxyvitamin D concentrations. Br J Dermatol. 2015;174:1068–1078.
   Web of Science ®Google Scholar
• Vaughan-Shaw P, O’Sullivan F, Farrington S, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116:1092–1110.
   PubMed Web of Science ®Google Scholar
• Jeanson N, Scadden D. Vitamin D receptor deletion leads to increased hematopoietic stem and progenitor cells residing in the spleen. Blood. 2010;116:4126–4129.
   PubMed Web of Science ®Google Scholar
• Friedman A. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26:6816–6828.
   PubMed Web of Science ®Google Scholar
• Yu S, Zhao J, Cantorna M. Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation. J Immunol. 2011;187:4907–4912.
   PubMed Web of Science ®Google Scholar
• Middleton P, Cullup H, Dickinson A, et al. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;30:223–228.
   PubMed Web of Science ®Google Scholar
• Bogunia-Kubik K, Middleton P, Norden J, et al. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int J Immunogenet. 2008;35:207–213.
   PubMed Web of Science ®Google Scholar
• Cho H, Shin D, Kim J, et al. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation. Clin Transplant. 2012;26:476–483.
   PubMed Web of Science ®Google Scholar
• Hall AC, Juckett MB. The role of vitamin D in hematologic disease and stem cell transplantation. Nutrients. 2013;5:2206–2221.
   PubMed Web of Science ®Google Scholar
• Uitterlinden S, Fang Y, van Meurs J, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143–156.
   PubMed Web of Science ®Google Scholar
• Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Arjumand W, Ahmad S, Seth A, et al. Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumor Biol. 2012;33:23–31.
   PubMedGoogle Scholar
• Sainz J, van Tornout J, Lorro M, et al. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;337:77–82.
   PubMed Web of Science ®Google Scholar
• MacDonald K, Hill G, Blazar B. Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood. 2017;129:13–21.
   PubMed Web of Science ®Google Scholar
• Nassereddine S, Rafei H, ElBahesh E, et al. Acute graft versus host disease: a comprehensive review. Anticancer Res. 2017;37:1547–1555.
   PubMed Web of Science ®Google Scholar
• Whitfield G, Remus L, Jurutka P, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–159.
   PubMed Web of Science ®Google Scholar
• Kamel A, El-Sharkawy N, Abd El-Fattah E, et al. Interferon gamma/IL10 ratio production in response to host antigens may predict acute graft versus host disease after allogeneic stem cell transplantation from a sibling. J Leuk. 2013;1:111.
   Google Scholar
• Przepiorka D, van Besien K, Khouri I, et al. Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Ann Oncol. 1999;10:527–532.
   PubMed Web of Science ®Google Scholar
• Kanda J, Hishizawa M, Utsunomiya A, et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood. 2012;119:2141–2148.
   PubMed Web of Science ®Google Scholar
• Kanda J, Brazauskas R, Hu Z, et al. Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations. Biol Blood Marrow Transplant. 2016;22:744–751.
   PubMed Web of Science ®Google Scholar
• Abdelfattah R, Zedan A, Kamel A, et al. Impact of acute graft versus host disease on survival after allogeneic peripheral blood stem cell transplantation. SECI Onc. 2016 [cited 2017 Jan 12]; [6 p.]. DOI:10.18056/seci2016.3
   Google Scholar
• Ishida T, Hishizawa M, Kato K, et al. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study. Biol Blood Marrow Transplant. 2013;19:1731–1739.
   PubMed Web of Science ®Google Scholar
• Donato M, Siegel D, Vesole D, et al. The graft-versus-myeloma effect: chronic graft-versus-host disease but not acute graft-versus-host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation. Biol Blood Marrow Transplant. 2014;20:1211–1216.
   PubMed Web of Science ®Google Scholar
• Gurman G, Ataca P, Atilla E, et al. Positive impact of chronic graft-versus host disease on survival in 928 allogeneic hematopoietic stem cell transplant recipients. ASH. 57th Annual Meeting and Exposition; 2015 Dec 5–8; Orlando, FL, poster1952.
   Google Scholar
• Baron F, Maris M, Sandmaier B, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol. 2005;23:1993–2003.
   PubMed Web of Science ®Google Scholar
• Baird K, Pavletic S. Chronic graft versus host disease. Curr Opin Hematol. 2006;6:426–435.
   Google Scholar
• Miflin G, Russell N, Franklin I, et al. An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation. Cytotherapy. 2000;2:423–428.
   PubMed Web of Science ®Google Scholar
• Kung A, Yeung S, Lau K. Vitamin D receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone. 1998;22:389–393.
   PubMed Web of Science ®Google Scholar